Your personal health profile, risk tolerance, timeline, and goals all play into the decision
Results announced in December 2025 confirmed the Phase 2 findings at a longer timepoint (Lilly Press Release, Dec 2025): The 28.7% weight loss at 68 weeks exceeds both semaglutide (~15% in STEP trials) and tirzepatide (~22.5% in SURMOUNT trials) at similar timepoints
Its challenging to study, as looking at the kidney, liver and blood vessels require more invasive procedures, though we may be able to use animal studies to fill the gaps
They found that vitamin D levels [25(OH)D] were positively associated with plasma glutathione (as vitamin D levels increased so did glutathione) and negatively associated with both GSSG and cysteine (as vitamin D levels increased, levels of GSSG and cysteine decreased)
How To Use Use it as directed by the physician